Mentor Capital, Inc. (OTCQB: MNTR) reports that it has entered into a
contract to receive $1,287,000 in funding to support its medical
marijuana efforts in exchange for 757,059 shares at a price of $1.70 per
share. The long-term funding will be delivered evenly over an eleven
year schedule which implies a 17.73% annual growth rate for Mentor
Capital, Inc. According to the Company, the investing party will become
a 4.9% shareholder in exchange for cash infusions over time equal to
approximately 11.5% of the current market capitalization of Mentor
Capital.
“This is the second step we have taken with this angel investor and we
appreciate the continued vote of confidence. In our previously concluded
$117,000 transaction, Mentor profited by a 30% discount over eight
months or a 45% annualized rate of return,” according to CEO, Chet
Billingsley. “These are each examples of how we attempt to make every
corporate investment action accretive to our shareholders.”
About Mentor Capital: The Company seeks to take significant
positions in medical marijuana and cannabis companies to provide public
market liquidity for founders, protection for investors and to incubate
private cannabis companies that have the potential to be spun off as
stand-alone public companies. Additional important information for
investors is presented at: www.MentorCapital.com.
This press release is neither an offer to sell, nor a solicitation of
offers to purchase, securities.
Forward Looking Statements: This press release contains
forward-looking statements within the meaning of the federal securities
laws, including statements concerning financial projections, financing
activities, corporate combinations, product development activities and
sales and licensing activities. Such forward-looking statements
are not guarantees of future results or performance, are sometimes
identified by words of condition such as “should,” “could,” “expects,”
“may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject
to a number of risks and uncertainties, known and unknown, that could
cause actual results to differ materially from those intended or
anticipated. Such risks include, without limitation:
nonperformance of investments, partner and portfolio difficulties,
potential delays in marketing and sales, problems securing the necessary
financing to continue operations, problems involving continued
illegality of cannabis products, potential of competitive
products, services, and technologies, difficulties experienced in
product development, in recruiting knowledgeable personnel and in
protecting intellectual property. Further information concerning
these and other risks is included in the Company’s 10-K filing which,
along with other very important information about the Company, can be
found here:
http://mentorcapital.com/disclosures/
The Company undertakes no obligation to update or revise such
forward-looking statements to reflect new information, events or
circumstances occurring after the date of this press release.
Copyright Business Wire 2015